“…Most studies characterized products in DNA models, e.g., nucleosides. Two-electron oxidation of dG yields 8-oxo-7,8-dihydro-2′-deoxyguanosine (dOG) and 5-carboxamido-5-formamido-2-iminohydantoin-2′-deoxyribonucleoside (d2Ih), ,− while four-electron oxidation of dG yields two diastereomers of spiroiminodihydantoin-2′-deoxyribonucleoside (dSp), two diastereomers of 5-guanidinohydantoin-2′-deoxyribonucleoside (dGh), and 2,5-diaminoimidazolone-2′-deoxyribonucleoside (dIz) that readily hydrolyzes to 2,2,4-triamino-2 H -oxazol-5-one-2′-deoxyribonucleoside (dZ). ,− The six-electron oxidation of dG yields dehydroguanidinohydantoin-2′-deoxynucleoside (dGh ox ), a compound of limited stability that ultimately decomposes to a ribosyl-urea lesion. ,− Another product that is formed during certain oxidations, but is not formally oxidized, is 2,6-diamino-4-hydroxy-5-formamidopyrimidine-2′-deoxyribonucleoside (Fapy·dG), a ring-opened hydrolysis product of dG (Scheme ). , The same products have been observed in oxidations of rG. , Many of these lesions resulting from dG oxidation have been observed in genomic samples of biological origin, − except d2Ih and dGh ox , whose cellular existence is awaiting confirmation. In cellular RNA samples, rOG is the only lesion that has been characterized thus far .…”